(Q34403660)

1 August 2017

Patient adherence to prescribed antimicrobial drug dosing regimens (English)

1 reference

1 August 2017

1 reference

Bernard Vrijens

1

1 reference

PubMed ID

15772145

1 August 2017

John Urquhart

series ordinal

2

1 reference

PubMed ID

15772145

1 August 2017

language of work or name

English

0 references

publication date

16 March 2005

1 reference

Journal of Antimicrobial Chemotherapy

1 August 2017

1 reference

1 August 2017

55

1 reference

1 August 2017

5

1 reference

1 August 2017

616-627

1 reference

INTERNAL MEDICINE IN THE 21ST CENTURY: Controlled drug delivery: therapeutic and pharmacological aspects

1 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Changes in prescribed drug doses after market introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

The electronic medication event monitor. Lessons for pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Microelectronic systems for monitoring and enhancing patient compliance with medication regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Medication compliance as a feature in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Use of electronic pill boxes to assess risk of poor treatment compliance: results of a large-scale trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

A comparison study of multiple measures of adherence to HIV protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Comparing compliance patterns between randomized treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Learning versus confirming in clinical drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

On estimating efficacy from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Electronic monitoring of variation in drug intakes can reduce bias and improve precision in pharmacokinetic/pharmacodynamic population studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Demonstrating effectiveness in a post-placebo era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Time to stop counting the tablets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Patient non-compliance with paper diaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Effect of adherence to newly initiated antiretroviral therapy on plasma viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Is average adherence to HIV antiretroviral therapy enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

The natural history of medication compliance in a drug trial: limitations of pill counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

The hope and the hazards of using compliance data in randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Adjusting treatment comparisons to account for non-randomized interventions: an example from an angina trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Practical properties of some structural mean analyses of the effect of compliance in randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

A method for the analysis of randomized trials with compliance information: an application to the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Beyond intention to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Enhancing medication compliance for people with serious mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI066

21 January 2018

Identifiers

DOI

10.1093/JAC/DKI066

1 reference

1 August 2017

1 reference

PubMed ID

15772145